TICAGRELORE

TICAGRELORE was reported 10052 times

TICAGRELORE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CAPILLARY FRAGILITY TEST 11 0.5789
1 EOSINOPHIL CATIONIC PROTEIN INCREASED 7 0.3889
2 DIABETIC MACROANGIOPATHY 12 0.3636
3 CAPILLARY FRAGILITY INCREASED 10 0.3448
4 APHERESIS RELATED COMPLICATION 5 0.3333
5 CHRONIC CORONARY SYNDROME 12 0.2609
6 HYPERSENSITIVITY MYOCARDITIS 22 0.1818
7 ALLERGIC EOSINOPHILIA 5 0.1429
8 VASCULAR STENT THROMBOSIS 250 0.1227
9 PLATELET AGGREGATION INHIBITION 10 0.1087
10 ECG SIGNS OF MYOCARDIAL ISCHAEMIA 19 0.0833
11 HAEMORRHAGIC PNEUMONIA 5 0.0806
12 CORONARY OSTIAL STENOSIS 9 0.0714
13 VENTRICULAR ASYSTOLE 12 0.0690
14 VASCULAR STENT STENOSIS 29 0.0689
15 LYMPHORRHOEA 10 0.0641
16 HAEMORRHAGIC CHOLECYSTITIS 8 0.0640
17 VASCULAR STENT RESTENOSIS 6 0.0638
18 SINUS ARREST 89 0.0567
19 VENTRICULAR HYPERKINESIA 5 0.0562
20 ACID BASE BALANCE ABNORMAL 12 0.0536
21 MYOCARDIAL HAEMORRHAGE 5 0.0455
22 INTESTINAL HAEMATOMA 8 0.0455
23 ELECTROCARDIOGRAM P WAVE ABNORMAL 11 0.0449
24 MILLER FISHER SYNDROME 10 0.0446
25 VASCULAR ACCESS SITE HAEMORRHAGE 7 0.0435
26 PLATELET AGGREGATION INCREASED 5 0.0413
27 COMPUTERISED TOMOGRAM HEAD ABNORMAL 4 0.0404
28 BRONCHIAL HAEMORRHAGE 12 0.0385
29 SPINAL SUBDURAL HAEMATOMA 5 0.0385
30 CORONARY REVASCULARISATION 6 0.0380
31 VASOMOTOR RHINITIS 5 0.0373
32 CHEYNE-STOKES RESPIRATION 9 0.0363
33 GASTRODUODENAL ULCER 15 0.0356
34 MUSCLE NECROSIS 31 0.0341
35 BREATH HOLDING 13 0.0339
36 ACCELERATED IDIOVENTRICULAR RHYTHM 5 0.0338
37 CATHETER SITE THROMBOSIS 9 0.0328
38 CARDIAC VENTRICULAR THROMBOSIS 42 0.0325
39 ELECTROCARDIOGRAM Q WAVE ABNORMAL 7 0.0299
40 CORONARY ARTERY RESTENOSIS 17 0.0284
41 SCAR PAIN 11 0.0273
42 CORONARY ARTERY DISSECTION 22 0.0256
43 COAGULATION FACTOR DEFICIENCY 4 0.0248
44 VASCULAR STENT OCCLUSION 10 0.0248
45 SUBCAPSULAR RENAL HAEMATOMA 5 0.0236
46 SINOATRIAL BLOCK 14 0.0235
47 PLATELET FUNCTION TEST ABNORMAL 5 0.0223
48 BASILAR ARTERY THROMBOSIS 4 0.0222
49 ATRIAL ENLARGEMENT 6 0.0221
50 DEVICE INTERACTION 5 0.0211
51 MERYCISM 6 0.0210
52 DROPPED HEAD SYNDROME 8 0.0203
53 DRUG-GENETIC INTERACTION 7 0.0196
54 GASTROINTESTINAL ANGIODYSPLASIA 8 0.0194
55 VENTRICULAR FAILURE 6 0.0192
56 ACQUIRED HAEMOPHILIA 19 0.0190
57 VENTRICULAR TACHYARRHYTHMIA 6 0.0188
58 CORNEAL INFECTION 4 0.0184
59 CORONARY ARTERY STENOSIS 92 0.0183
60 LIPID METABOLISM DISORDER 7 0.0182
61 HAEMORRHAGIC INFARCTION 10 0.0182
62 PROGRESSIVE MULTIPLE SCLEROSIS 21 0.0182
63 ANGINA UNSTABLE 116 0.0178
64 PERCUTANEOUS CORONARY INTERVENTION 5 0.0175
65 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 154 0.0174
66 LABELLED DRUG-DRUG INTERACTION ISSUE 25 0.0173
67 AUTOIMMUNE MYOSITIS 8 0.0169
68 DELAYED GRAFT FUNCTION 12 0.0169
69 PERIPHERAL ARTERY STENOSIS 8 0.0167
70 BRADYARRHYTHMIA 27 0.0164
71 MYOPATHY TOXIC 10 0.0162
72 RETROPERITONEAL HAEMATOMA 35 0.0158
73 RHABDOMYOLYSIS 660 0.0158
74 AORTIC VALVE CALCIFICATION 8 0.0156
75 SPINAL EPIDURAL HAEMATOMA 9 0.0153
76 ALVEOLAR PROTEINOSIS 9 0.0152
77 GIARDIASIS 5 0.0147
78 TACHYPHYLAXIS 5 0.0143
79 VASOSPASM 13 0.0141
80 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 25 0.0140
81 PROCALCITONIN INCREASED 16 0.0136
82 CHOLESTATIC LIVER INJURY 30 0.0135
83 ACUTE MYOCARDIAL INFARCTION 393 0.0133
84 BLADDER TAMPONADE 4 0.0132
85 ELECTROCARDIOGRAM PR PROLONGATION 10 0.0131
86 MYOPATHY 113 0.0131
87 CREATINE KINASE INCREASED 10 0.0130
88 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 43 0.0130
89 OVERLAP SYNDROME 9 0.0129
90 FALSE NEGATIVE INVESTIGATION RESULT 9 0.0128
91 CORONARY ARTERY THROMBOSIS 25 0.0124
92 MIXED LIVER INJURY 37 0.0123
93 STENOSIS 23 0.0122
94 ACUTE CORONARY SYNDROME 101 0.0122
95 SPONTANEOUS HAEMATOMA 9 0.0120
96 INTERMITTENT CLAUDICATION 19 0.0120
97 ARTERIAL THROMBOSIS 23 0.0119
98 BRAIN NATRIURETIC PEPTIDE INCREASED 36 0.0117
99 BLOOD LOSS ANAEMIA 26 0.0115
100 ARTERIAL STENOSIS 10 0.0114
101 BRAIN MIDLINE SHIFT 6 0.0114
102 HAEMOPERITONEUM 9 0.0112
103 TROPONIN T INCREASED 14 0.0110
104 ASPHYXIA 90 0.0110
105 SINUS NODE DYSFUNCTION 20 0.0109
106 DIET NONCOMPLIANCE 4 0.0109
107 PANCREATITIS HAEMORRHAGIC 5 0.0108
108 INTRACRANIAL HAEMATOMA 6 0.0107
109 MYASTHENIC SYNDROME 8 0.0103
110 SUBCUTANEOUS HAEMATOMA 13 0.0102
111 RESPIRATORY TRACT HAEMORRHAGE 6 0.0101
112 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 5 0.0100
113 HEPARIN-INDUCED THROMBOCYTOPENIA 48 0.0097
114 DRUG-DISEASE INTERACTION 7 0.0095
115 THROMBOSIS IN DEVICE 31 0.0094
116 PERICARDIAL HAEMORRHAGE 20 0.0091
117 ORTHOPNOEA 29 0.0091
118 CARDIAC ANEURYSM 9 0.0091
119 IMMUNE-MEDIATED MYOSITIS 25 0.0091
120 RETROPERITONEAL HAEMORRHAGE 22 0.0089
121 ATRIOVENTRICULAR BLOCK COMPLETE 59 0.0088
122 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 7 0.0086
123 INSULIN-LIKE GROWTH FACTOR INCREASED 12 0.0084
124 HEPATITIS CHOLESTATIC 50 0.0083
125 DIASTOLIC DYSFUNCTION 25 0.0081
126 ANGIOPLASTY 12 0.0080
127 SHOCK HAEMORRHAGIC 64 0.0079
128 AORTIC VALVE STENOSIS 14 0.0078
129 BRAIN HERNIATION 23 0.0077
130 MICROCYTIC ANAEMIA 16 0.0077
131 VASCULAR PSEUDOANEURYSM 13 0.0075
132 SUBARACHNOID HAEMORRHAGE 76 0.0075
133 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 6 0.0074
134 SPLENIC RUPTURE 12 0.0073
135 RIGHT VENTRICULAR DYSFUNCTION 8 0.0073
136 CORONARY ARTERY OCCLUSION 96 0.0070
137 HIGH DENSITY LIPOPROTEIN DECREASED 23 0.0069
138 EXTREMITY NECROSIS 12 0.0069
139 PRURITUS ALLERGIC 8 0.0069
140 DEMYELINATING POLYNEUROPATHY 7 0.0068
141 POLYMYOSITIS 12 0.0068
142 ARTERIOSPASM CORONARY 27 0.0067
143 INTESTINAL POLYP 11 0.0067
144 DIVERTICULUM INTESTINAL HAEMORRHAGIC 15 0.0067
145 CARDIAC DEATH 8 0.0066
146 ATRIOVENTRICULAR BLOCK SECOND DEGREE 20 0.0066
147 MELAENA 145 0.0066
148 PULMONARY HAEMORRHAGE 51 0.0065
149 MYOPERICARDITIS 5 0.0064
150 LOWER GASTROINTESTINAL HAEMORRHAGE 47 0.0064
151 HEPATIC CYTOLYSIS 81 0.0063
152 PLATELET DISORDER 16 0.0063
153 CARDIOGENIC SHOCK 90 0.0063
154 ANGINA PECTORIS 179 0.0062
155 DYSPNOEA AT REST 18 0.0062
156 WALKING DISABILITY 13 0.0062
157 EXTRADURAL HAEMATOMA 8 0.0060
158 MEAN CELL HAEMOGLOBIN INCREASED 10 0.0060
159 RED CELL DISTRIBUTION WIDTH INCREASED 25 0.0060
160 RECTAL ULCER 7 0.0060
161 AMAUROSIS 5 0.0059
162 PULMONARY ALVEOLAR HAEMORRHAGE 33 0.0059
163 HAEMATOMA MUSCLE 7 0.0058
164 VASCULAR RUPTURE 9 0.0058
165 GASTRITIS EROSIVE 27 0.0058
166 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 8 0.0057
167 HAEMORRHAGE INTRACRANIAL 85 0.0057
168 BLOOD PRESSURE SYSTOLIC ABNORMAL 14 0.0057
169 ABDOMINAL WALL HAEMATOMA 11 0.0056
170 CATHETER SITE HAEMORRHAGE 14 0.0056
171 MYOSITIS 50 0.0056
172 MALLORY-WEISS SYNDROME 7 0.0055
173 DRUG INTERACTION 875 0.0055
174 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 12 0.0055
175 OBSTRUCTION GASTRIC 7 0.0054
176 VENTRICULAR FIBRILLATION 60 0.0054
177 MYOCARDIAL NECROSIS MARKER INCREASED 9 0.0054
178 POTENTIATING DRUG INTERACTION 18 0.0054
179 UPPER GASTROINTESTINAL HAEMORRHAGE 90 0.0053
180 MYELOFIBROSIS 16 0.0053
181 LOSS OF CONTROL OF LEGS 20 0.0053
182 TELANGIECTASIA 5 0.0052
183 MACROCYTOSIS 6 0.0052
184 CARDIAC FAILURE CHRONIC 22 0.0052
185 FEAR OF DISEASE 9 0.0051
186 ATRIOVENTRICULAR BLOCK 39 0.0050
187 ANTICHOLINERGIC SYNDROME 8 0.0050
188 HYPOCHROMIC ANAEMIA 5 0.0049
189 CEREBELLAR HAEMORRHAGE 7 0.0049
190 DUODENAL ULCER HAEMORRHAGE 14 0.0049
191 IRON DEFICIENCY ANAEMIA 45 0.0049
192 KOUNIS SYNDROME 11 0.0048
193 INTRA-ABDOMINAL HAEMATOMA 6 0.0048
194 CARDIAC TAMPONADE 23 0.0048
195 EMBOLIC STROKE 17 0.0048
196 MITRAL VALVE INCOMPETENCE 53 0.0047
197 CORONARY ARTERY DISEASE 141 0.0047
198 THROMBOCYTOSIS 17 0.0046
199 CLAUSTROPHOBIA 5 0.0046
200 GASTROINTESTINAL ULCER 10 0.0045
201 HAEMOTHORAX 13 0.0045
202 CARDIAC DISCOMFORT 9 0.0045
203 HAEMATOMA 115 0.0044
204 INHIBITORY DRUG INTERACTION 7 0.0044
205 HAEMATOCRIT INCREASED 10 0.0044
206 ISCHAEMIC HEPATITIS 6 0.0044
207 IMMUNE THROMBOCYTOPENIA 20 0.0044
208 DUODENITIS 13 0.0042
209 EOSINOPHILIA 74 0.0042
210 TROPONIN INCREASED 32 0.0042
211 POST PROCEDURAL HAEMATOMA 7 0.0041
212 NON-CARDIAC CHEST PAIN 13 0.0041
213 WOUND COMPLICATION 14 0.0041
214 DUODENAL PERFORATION 4 0.0041
215 PULSELESS ELECTRICAL ACTIVITY 17 0.0041
216 ACUTE KIDNEY INJURY 617 0.0040
217 THROMBOTIC THROMBOCYTOPENIC PURPURA 14 0.0040
218 FACIAL PARESIS 14 0.0040
219 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 13 0.0039
220 BRAIN STEM INFARCTION 4 0.0039
221 TACHYPNOEA 53 0.0039
222 COAGULATION TIME PROLONGED 6 0.0039
223 CEREBRAL HAEMATOMA 13 0.0039
224 DUODENAL ULCER 27 0.0038
225 CONDUCTION DISORDER 7 0.0038
226 VENTRICULAR TACHYCARDIA 63 0.0038
227 ABNORMAL LOSS OF WEIGHT 26 0.0038
228 ESCHERICHIA URINARY TRACT INFECTION 16 0.0038
229 CEREBRAL ARTERY OCCLUSION 4 0.0037
230 LEFT VENTRICULAR DYSFUNCTION 25 0.0037
231 ATRIOVENTRICULAR BLOCK FIRST DEGREE 16 0.0037
232 HYPOPROTEINAEMIA 7 0.0037
233 BENIGN PROSTATIC HYPERPLASIA 19 0.0037
234 NORMOCHROMIC NORMOCYTIC ANAEMIA 11 0.0037
235 THROMBOCYTOPENIC PURPURA 5 0.0037
236 CLOSTRIDIUM TEST POSITIVE 8 0.0036
237 PERITONEAL HAEMORRHAGE 5 0.0036
238 MYOCARDIAL ISCHAEMIA 41 0.0036
239 COLITIS MICROSCOPIC 17 0.0036
240 PERIPHERAL ARTERY OCCLUSION 5 0.0036
241 HYPOVOLAEMIC SHOCK 17 0.0035
242 CHRONIC GASTRITIS 8 0.0035
243 ARTERIAL HAEMORRHAGE 4 0.0035
244 INTRACRANIAL ANEURYSM 14 0.0035
245 SMALL INTESTINAL HAEMORRHAGE 7 0.0035
246 PRODUCT MONITORING ERROR 5 0.0035
247 CEREBRAL HAEMORRHAGE 123 0.0034
248 VENTRICULAR HYPOKINESIA 11 0.0034
249 SINUS BRADYCARDIA 33 0.0034
250 LIVER INJURY 83 0.0034
251 CHEST DISCOMFORT 346 0.0034
252 GASTROINTESTINAL HAEMORRHAGE 280 0.0033
253 GASTRITIS HAEMORRHAGIC 5 0.0033
254 HAEMODYNAMIC INSTABILITY 25 0.0033
255 MYOGLOBIN BLOOD INCREASED 5 0.0033
256 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 84 0.0033
257 ISCHAEMIC CARDIOMYOPATHY 10 0.0033
258 INTRACARDIAC THROMBUS 10 0.0033
259 GLOMERULAR FILTRATION RATE DECREASED 40 0.0033
260 ARTERIOSCLEROSIS 30 0.0032
261 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 4 0.0031
262 BRADYCARDIA 165 0.0031
263 DIVERTICULUM 22 0.0031
264 ECCHYMOSIS 21 0.0031
265 MYOCARDIAL INFARCTION 534 0.0031
266 LARGE INTESTINE POLYP 21 0.0030
267 CELL DEATH 6 0.0030
268 TONGUE DISCOLOURATION 13 0.0030
269 SUBDURAL HAEMORRHAGE 8 0.0029
270 HEPATITIS ACUTE 19 0.0029
271 RASH MACULO-PAPULAR 65 0.0029
272 QUADRIPLEGIA 6 0.0029
273 SPINAL STENOSIS 12 0.0029
274 ANURIA 25 0.0029
275 CARDIOVERSION 4 0.0029
276 URINARY BLADDER HAEMORRHAGE 6 0.0028
277 LOW DENSITY LIPOPROTEIN INCREASED 22 0.0028
278 SLEEP DEFICIT 6 0.0028
279 INTRAVENTRICULAR HAEMORRHAGE 7 0.0028
280 ANAL FISTULA 15 0.0028
281 GASTROINTESTINAL TUBE INSERTION 7 0.0028
282 SKIN WEEPING 10 0.0028
283 TUMOUR HAEMORRHAGE 8 0.0028
284 SUBDURAL HAEMATOMA 40 0.0028
285 CORONARY ARTERIAL STENT INSERTION 14 0.0028
286 HAEMOPTYSIS 77 0.0028
287 OLIGURIA 17 0.0027
288 VENTRICULAR ARRHYTHMIA 10 0.0027
289 MEAN CELL HAEMOGLOBIN DECREASED 5 0.0027
290 NOSOCOMIAL INFECTION 6 0.0027
291 METABOLIC ACIDOSIS 87 0.0027
292 CARDIAC FAILURE ACUTE 18 0.0027
293 PERIPHERAL ISCHAEMIA 11 0.0027
294 HAEMORRHAGIC STROKE 21 0.0027
295 ILEUS PARALYTIC 12 0.0027
296 HAEMATEMESIS 68 0.0027
297 TORSADE DE POINTES 21 0.0027
298 RECTAL HAEMORRHAGE 115 0.0027
299 ACUTE PULMONARY OEDEMA 15 0.0027
300 EUGLYCAEMIC DIABETIC KETOACIDOSIS 11 0.0027
301 MULTIPLE ORGAN DYSFUNCTION SYNDROME 75 0.0026
302 LEFT VENTRICULAR FAILURE 9 0.0026
303 GRANULOMA 9 0.0026
304 HAEMATURIA 89 0.0026
305 RHEUMATIC DISORDER 5 0.0026
306 RALES 15 0.0026
307 EJECTION FRACTION DECREASED 40 0.0026
308 LEFT VENTRICULAR HYPERTROPHY 11 0.0026
309 CHOLESTASIS 49 0.0025
310 SKIN TIGHTNESS 12 0.0025
311 IDIOPATHIC PULMONARY FIBROSIS 10 0.0025
312 GASTRIC ULCER HAEMORRHAGE 14 0.0025
313 INFARCTION 17 0.0025
314 CARDIAC ARREST 205 0.0025
315 CUTANEOUS VASCULITIS 9 0.0025
316 BRONCHITIS CHRONIC 6 0.0025
317 FAECES DISCOLOURED 53 0.0024
318 ANAPHYLACTOID REACTION 10 0.0024
319 SUFFOCATION FEELING 6 0.0024
320 ARTERIAL OCCLUSIVE DISEASE 19 0.0024
321 ANAL ABSCESS 13 0.0024
322 ISCHAEMIA 11 0.0024
323 DRUG-INDUCED LIVER INJURY 75 0.0024
324 BLOOD TRIGLYCERIDES INCREASED 42 0.0024
325 ATTENTION DEFICIT HYPERACTIVITY DISORDER 10 0.0024
326 DERMATOMYOSITIS 6 0.0024
327 PERFORMANCE STATUS DECREASED 11 0.0024
328 SUDDEN CARDIAC DEATH 8 0.0023
329 ELECTROLYTE IMBALANCE 27 0.0023
330 PETECHIAE 24 0.0023
331 ORTHOSTATIC HYPOTENSION 40 0.0023
332 BLOOD CREATINE PHOSPHOKINASE INCREASED 66 0.0023
333 ARTERIOSCLEROSIS CORONARY ARTERY 15 0.0023
334 ELECTROCARDIOGRAM T WAVE INVERSION 5 0.0023
335 HAEMORRHAGE SUBCUTANEOUS 8 0.0023
336 BLOOD URIC ACID INCREASED 13 0.0022
337 HYPERURICAEMIA 9 0.0022
338 TOXIC SKIN ERUPTION 22 0.0022
339 CHEST PAIN 404 0.0022
340 GASTRIC HAEMORRHAGE 25 0.0022
341 CHRONIC MYELOID LEUKAEMIA 10 0.0022
342 HIATUS HERNIA 28 0.0022
343 CHOLECYSTITIS INFECTIVE 6 0.0022
344 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 5 0.0021
345 CARDIOTOXICITY 19 0.0021
346 GINGIVAL BLEEDING 29 0.0021
347 VENTRICULAR EXTRASYSTOLES 22 0.0021
348 JOINT LOCK 6 0.0021
349 BLOOD BICARBONATE DECREASED 4 0.0021
350 NEUTROPENIC SEPSIS 15 0.0021
351 OESOPHAGEAL ULCER 8 0.0021
352 COLITIS ISCHAEMIC 14 0.0021
353 SUPRAVENTRICULAR EXTRASYSTOLES 7 0.0021
354 MONOPLEGIA 9 0.0021
355 MUSCLE RUPTURE 8 0.0021
356 HYPOVOLAEMIA 12 0.0020
357 ADRENOCORTICAL INSUFFICIENCY ACUTE 4 0.0020
358 HAEMORRHOIDAL HAEMORRHAGE 10 0.0020
359 HAEMORRHAGIC ANAEMIA 9 0.0020
360 HAEMORRHAGE 213 0.0020
361 FUNCTIONAL GASTROINTESTINAL DISORDER 7 0.0020
362 DYSPNOEA EXERTIONAL 76 0.0020
363 TRICUSPID VALVE INCOMPETENCE 16 0.0020
364 SUPRAVENTRICULAR TACHYCARDIA 19 0.0020
365 CARDIAC FAILURE 159 0.0020
366 HYPERTENSIVE CRISIS 22 0.0020
367 PROSTATITIS 6 0.0020
368 HAEMORRHAGE URINARY TRACT 5 0.0020
369 CEREBRAL ISCHAEMIA 10 0.0019
370 NEPHROGENIC ANAEMIA 9 0.0019
371 CAROTID ARTERY OCCLUSION 7 0.0019
372 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 5 0.0019
373 MOUTH SWELLING 11 0.0019
374 GASTRIC ULCER 36 0.0019
375 RENAL CYST 15 0.0019
376 DRUG RESISTANCE 48 0.0019
377 CLUMSINESS 5 0.0018
378 PANIC DISORDER 7 0.0018
379 SKIN MASS 12 0.0018
380 PLANTAR FASCIITIS 6 0.0018
381 ANAL HAEMORRHAGE 5 0.0018
382 ELECTROCARDIOGRAM ABNORMAL 14 0.0018
383 IRON DEFICIENCY 8 0.0018
384 MOUTH HAEMORRHAGE 13 0.0018
385 TUBULOINTERSTITIAL NEPHRITIS 33 0.0018
386 BUNDLE BRANCH BLOCK RIGHT 8 0.0017
387 VARICOSE VEIN 9 0.0017
388 HYPERTRANSAMINASAEMIA 12 0.0017
389 ANAEMIA 329 0.0017
390 HAEMOGLOBIN DECREASED 177 0.0017
391 POST PROCEDURAL HAEMORRHAGE 20 0.0017
392 CAROTID ARTERY STENOSIS 6 0.0017
393 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 7 0.0017
394 HEMIPARESIS 29 0.0017
395 AORTIC ANEURYSM 13 0.0017
396 SHOCK 39 0.0017
397 BLOOD URINE PRESENT 32 0.0017
398 HYPERLIPIDAEMIA 20 0.0017
399 HYPOALBUMINAEMIA 13 0.0017
400 GOUT 30 0.0017
401 MUSCLE FATIGUE 7 0.0017
402 INCORRECT DRUG ADMINISTRATION RATE 7 0.0016
403 THROMBOTIC MICROANGIOPATHY 16 0.0016
404 HEPATIC PAIN 7 0.0016
405 GASTRITIS 43 0.0016
406 ATRIAL FLUTTER 13 0.0016
407 HYPERKALAEMIA 57 0.0016
408 LIVER FUNCTION TEST ABNORMAL 47 0.0016
409 HYPOTONIA 16 0.0016
410 PERONEAL NERVE PALSY 9 0.0016
411 RHINITIS ALLERGIC 7 0.0016
412 CLAVICLE FRACTURE 6 0.0016
413 LIPASE INCREASED 12 0.0016
414 EPISTAXIS 117 0.0016
415 PHLEBITIS 8 0.0016
416 AORTIC ARTERIOSCLEROSIS 4 0.0016
417 PROSTATOMEGALY 6 0.0015
418 HEPATITIS 39 0.0015
419 PULMONARY CONGESTION 20 0.0015
420 PEPTIC ULCER 5 0.0015
421 BLOOD PRESSURE DIASTOLIC DECREASED 11 0.0015
422 ARRHYTHMIA 70 0.0015
423 PULSE ABSENT 7 0.0015
424 PURPURA 13 0.0015
425 HYDROCEPHALUS 8 0.0015
426 PANCREATITIS ACUTE 33 0.0015
427 ABNORMAL WEIGHT GAIN 18 0.0015
428 ISCHAEMIC STROKE 26 0.0015
429 PUSTULAR PSORIASIS 5 0.0015
430 DIZZINESS POSTURAL 14 0.0014
431 HEMIPLEGIA 12 0.0014
432 MICTURITION DISORDER 5 0.0014
433 VITAMIN D DEFICIENCY 14 0.0014
434 BLOOD CREATININE INCREASED 93 0.0014
435 ANTIPSYCHOTIC DRUG LEVEL INCREASED 4 0.0014
436 NECROTISING FASCIITIS 5 0.0014
437 INFLAMMATORY MARKER INCREASED 7 0.0014
438 AORTIC VALVE INCOMPETENCE 6 0.0014
439 CIRCULATORY COLLAPSE 24 0.0014
440 ABSCESS LIMB 6 0.0014
441 ERYTHEMA MULTIFORME 13 0.0014
442 CARDIAC FLUTTER 9 0.0014
443 EXERCISE TOLERANCE DECREASED 8 0.0014
444 DYSLIPIDAEMIA 7 0.0014
445 HAEMATOCHEZIA 76 0.0014
446 TRANSPLANT REJECTION 11 0.0014
447 URINE OUTPUT DECREASED 12 0.0014
448 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
449 ENDOCARDITIS 7 0.0014
450 STENT PLACEMENT 11 0.0014
451 DYSPNOEA 770 0.0014
452 SKIN NECROSIS 7 0.0013
453 BRAIN OEDEMA 17 0.0013
454 RENAL TUBULAR NECROSIS 13 0.0013
455 BLOOD PRESSURE SYSTOLIC DECREASED 6 0.0013
456 FACE INJURY 5 0.0013
457 PRESYNCOPE 32 0.0013
458 THROMBOCYTOPENIA 147 0.0013
459 BLOOD UREA INCREASED 22 0.0013
460 DRUG LEVEL ABOVE THERAPEUTIC 6 0.0013
461 HYPOKINESIA 19 0.0013
462 DIABETIC FOOT 4 0.0013
463 CHEST X-RAY ABNORMAL 4 0.0013
464 BLOOD PRESSURE DIASTOLIC INCREASED 6 0.0013
465 HEPATIC FUNCTION ABNORMAL 48 0.0013
466 DIARRHOEA HAEMORRHAGIC 12 0.0013
467 BLOOD PRESSURE SYSTOLIC INCREASED 25 0.0013
468 OESOPHAGITIS 14 0.0013
469 SWOLLEN TONGUE 40 0.0013
470 EPIGASTRIC DISCOMFORT 5 0.0013
471 TRANSAMINASES INCREASED 28 0.0013
472 SLEEP APNOEA SYNDROME 24 0.0013
473 PERICARDIAL EFFUSION 29 0.0013
474 DIABETES MELLITUS INADEQUATE CONTROL 22 0.0012
475 BRADYPHRENIA 8 0.0012
476 PNEUMONITIS 33 0.0012
477 HAEMATOCRIT DECREASED 24 0.0012
478 ANXIETY DISORDER 4 0.0012
479 ACUTE RESPIRATORY FAILURE 23 0.0012
480 BLOOD THYROID STIMULATING HORMONE INCREASED 11 0.0012
481 COLD SWEAT 21 0.0012
482 FACIAL PARALYSIS 10 0.0012
483 SQUAMOUS CELL CARCINOMA 11 0.0012
484 DISTURBANCE IN ATTENTION 63 0.0012
485 LEUKAEMIA 11 0.0012
486 PERIPHERAL VASCULAR DISORDER 6 0.0012
487 BASAL CELL CARCINOMA 18 0.0012
488 CHAPPED LIPS 5 0.0012
489 SYNCOPE 115 0.0011
490 HYPOTENSION 230 0.0011
491 EXTRASYSTOLES 8 0.0011
492 DIVERTICULUM INTESTINAL 5 0.0011
493 HYPERCHOLESTEROLAEMIA 11 0.0011
494 HEPATOCELLULAR INJURY 16 0.0011
495 HEPATIC STEATOSIS 21 0.0011
496 DERMATITIS ALLERGIC 14 0.0011
497 HEART RATE DECREASED 39 0.0011
498 DRUG ADMINISTRATION ERROR 34 0.0011
499 TENDONITIS 17 0.0011
500 GENERAL PHYSICAL HEALTH DETERIORATION 127 0.0011
501 RESPIRATORY FAILURE 80 0.0011
502 ALANINE AMINOTRANSFERASE INCREASED 67 0.0011
503 INTESTINAL ISCHAEMIA 6 0.0011
504 PRODUCT ADMINISTRATION ERROR 22 0.0011
505 DRUG LEVEL INCREASED 18 0.0011
506 ELECTROCARDIOGRAM QT PROLONGED 39 0.0011
507 DRUG LEVEL DECREASED 11 0.0011
508 SKIN HAEMORRHAGE 16 0.0011
509 STEVENS-JOHNSON SYNDROME 24 0.0011
510 INTERCEPTED MEDICATION ERROR 5 0.0011
511 HELICOBACTER INFECTION 11 0.0011
512 KETOACIDOSIS 8 0.0011
513 THROMBOSIS 86 0.0011
514 OBESITY 17 0.0011
515 PALLOR 29 0.0011
516 CEREBRAL INFARCTION 26 0.0011
517 CHRONIC LYMPHOCYTIC LEUKAEMIA 5 0.0011
518 SYNOVITIS 19 0.0011
519 CLOSTRIDIUM DIFFICILE INFECTION 23 0.0011
520 LEUKOCYTOSIS 19 0.0010
521 BLOOD ALKALINE PHOSPHATASE INCREASED 26 0.0010
522 POST-TRAUMATIC STRESS DISORDER 7 0.0010
523 DISSOCIATION 8 0.0010
524 END STAGE RENAL DISEASE 19 0.0010
525 ASPARTATE AMINOTRANSFERASE INCREASED 55 0.0010
526 HYPERVENTILATION 6 0.0010
527 CONCUSSION 8 0.0010
528 HYPONATRAEMIA 58 0.0010
529 APNOEA 8 0.0010
530 MUSCULAR WEAKNESS 115 0.0010
531 MYALGIA 172 0.0010
532 ANEURYSM 5 0.0010
533 BLOOD PRESSURE INADEQUATELY CONTROLLED 6 0.0010
534 OROPHARYNGEAL DISCOMFORT 9 0.0010
535 DISSEMINATED INTRAVASCULAR COAGULATION 14 0.0010
536 GLYCOSYLATED HAEMOGLOBIN INCREASED 25 0.0010
537 MYASTHENIA GRAVIS 8 0.0010
538 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
539 RESPIRATORY DEPRESSION 12 0.0010
540 CHRONIC KIDNEY DISEASE 74 0.0010
541 QUALITY OF LIFE DECREASED 13 0.0010
542 AORTIC DISSECTION 4 0.0010
543 HYPERBILIRUBINAEMIA 10 0.0010
544 C-REACTIVE PROTEIN INCREASED 35 0.0010
545 COAGULOPATHY 16 0.0010
546 ATRIAL FIBRILLATION 93 0.0010
547 BUNDLE BRANCH BLOCK LEFT 4 0.0009
548 EATING DISORDER 20 0.0009
549 ENTERITIS 6 0.0009
550 SKIN LESION 25 0.0009
551 SPINAL OSTEOARTHRITIS 8 0.0009
552 SARS-COV-2 TEST POSITIVE 12 0.0009
553 BLOOD CREATINE INCREASED 4 0.0009
554 JAUNDICE 24 0.0009
555 GASTROENTERITIS 13 0.0009
556 NEUROLOGICAL SYMPTOM 5 0.0009
557 BLOOD PRESSURE DECREASED 58 0.0009
558 HAEMORRHOIDS 17 0.0009
559 UROSEPSIS 8 0.0009
560 AGRANULOCYTOSIS 16 0.0009
561 STRESS CARDIOMYOPATHY 5 0.0009
562 TRANSIENT ISCHAEMIC ATTACK 29 0.0009
563 CONTRAINDICATED PRODUCT ADMINISTERED 26 0.0009
564 HEPATOTOXICITY 19 0.0009
565 HYPOXIA 30 0.0009
566 DRUG ERUPTION 15 0.0008
567 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
568 EOSINOPHIL COUNT INCREASED 7 0.0008
569 LIVER FUNCTION TEST INCREASED 18 0.0008
570 ANGIOEDEMA 37 0.0008
571 EAR PAIN 16 0.0008
572 DIABETIC NEUROPATHY 4 0.0008
573 ABDOMINAL TENDERNESS 4 0.0008
574 HEPATIC ENZYME INCREASED 54 0.0008
575 INTERNAL HAEMORRHAGE 9 0.0008
576 MOTOR DYSFUNCTION 8 0.0008
577 SLUGGISHNESS 8 0.0008
578 BOWEL MOVEMENT IRREGULARITY 6 0.0008
579 HAEMARTHROSIS 7 0.0008
580 ERECTILE DYSFUNCTION 20 0.0008
581 HAEMOLYSIS 6 0.0008
582 UNRESPONSIVE TO STIMULI 20 0.0008
583 LACTIC ACIDOSIS 25 0.0008
584 RED BLOOD CELL COUNT DECREASED 22 0.0008
585 CONTUSION 74 0.0008
586 PLATELET COUNT INCREASED 10 0.0008
587 CARDIO-RESPIRATORY ARREST 32 0.0008
588 AGEUSIA 19 0.0008
589 POLYNEUROPATHY 9 0.0008
590 CARDIOVASCULAR DISORDER 19 0.0007
591 MOVEMENT DISORDER 24 0.0007
592 GASTROOESOPHAGEAL REFLUX DISEASE 59 0.0007
593 ABNORMAL FAECES 6 0.0007
594 HICCUPS 6 0.0007
595 APHASIA 22 0.0007
596 RENAL IMPAIRMENT 61 0.0007
597 PALPITATIONS 85 0.0007
598 TOXIC EPIDERMAL NECROLYSIS 11 0.0007
599 GAMMA-GLUTAMYLTRANSFERASE INCREASED 16 0.0007
600 LIP SWELLING 24 0.0007
601 DISEASE RECURRENCE 34 0.0007
602 SEPTIC SHOCK 31 0.0007
603 THERAPY NON-RESPONDER 32 0.0007
604 BLOOD CALCIUM DECREASED 8 0.0007
605 WHITE BLOOD CELL COUNT INCREASED 27 0.0007
606 ANAPHYLACTIC SHOCK 18 0.0007
607 BRAIN INJURY 7 0.0007
608 DEAFNESS 18 0.0007
609 VASCULITIS 8 0.0007
610 RENAL FAILURE 90 0.0007
611 BLOOD PRESSURE FLUCTUATION 16 0.0007
612 MEDICATION ERROR 37 0.0007
613 CHROMATURIA 15 0.0007
614 HEAD INJURY 21 0.0007
615 JOINT DISLOCATION 7 0.0007
616 DEPRESSED MOOD 35 0.0007
617 OSTEOARTHRITIS 28 0.0007
618 URINARY RETENTION 22 0.0007
619 BREAST PAIN 7 0.0007
620 HYPERTENSION 139 0.0007
621 PERIPHERAL COLDNESS 9 0.0007
622 PHARYNGEAL OEDEMA 10 0.0006
623 HYPOMAGNESAEMIA 9 0.0006
624 CHOLANGITIS 4 0.0006
625 HYPERHIDROSIS 83 0.0006
626 DIZZINESS 317 0.0006
627 ASTHENIA 238 0.0006
628 INTERNATIONAL NORMALISED RATIO INCREASED 18 0.0006
629 PROTEINURIA 12 0.0006
630 BRONCHOSPASM 9 0.0006
631 PARALYSIS 9 0.0006
632 TOOTH LOSS 13 0.0006
633 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0006
634 SENSORY LOSS 5 0.0006
635 ATELECTASIS 6 0.0006
636 CARDIAC DISORDER 58 0.0006
637 BLOOD POTASSIUM INCREASED 10 0.0006
638 AUTOIMMUNE DISORDER 6 0.0006
639 MYOCARDITIS 7 0.0006
640 POLYURIA 5 0.0006
641 SLEEP DISORDER 43 0.0006
642 PLEURAL EFFUSION 37 0.0006
643 HYPOKALAEMIA 28 0.0006
644 BONE DISORDER 11 0.0006
645 CONDITION AGGRAVATED 183 0.0006
646 RASH MACULAR 21 0.0006
647 EYE HAEMORRHAGE 8 0.0006
648 ANAPHYLACTIC REACTION 33 0.0006
649 OSTEOPENIA 9 0.0006
650 VERTIGO 36 0.0006
651 WHEEZING 35 0.0006
652 LIMB INJURY 16 0.0006
653 PROSTATIC SPECIFIC ANTIGEN INCREASED 8 0.0006
654 NOCTURIA 7 0.0006
655 AUTOIMMUNE HEPATITIS 4 0.0006
656 DEVICE DISLOCATION 25 0.0006
657 SEPSIS 64 0.0006
658 LOWER LIMB FRACTURE 11 0.0006
659 LOSS OF CONSCIOUSNESS 73 0.0006
660 OXYGEN SATURATION DECREASED 32 0.0006
661 DEVICE OCCLUSION 8 0.0006
662 INCONTINENCE 6 0.0006
663 SINUS TACHYCARDIA 8 0.0006
664 DYSPEPSIA 55 0.0006
665 BLOOD PRESSURE ABNORMAL 11 0.0006
666 DERMATITIS BULLOUS 4 0.0006
667 MUSCLE ATROPHY 7 0.0006
668 LUPUS-LIKE SYNDROME 5 0.0006
669 LOWER RESPIRATORY TRACT INFECTION 25 0.0005
670 INCREASED TENDENCY TO BRUISE 5 0.0005
671 PULMONARY MASS 8 0.0005
672 HEPATIC ENCEPHALOPATHY 5 0.0005
673 EYE INFECTION 6 0.0005
674 PULMONARY HYPERTENSION 11 0.0005
675 THERAPEUTIC RESPONSE DECREASED 32 0.0005
676 POLLAKIURIA 22 0.0005
677 COMA 25 0.0005
678 INCREASED APPETITE 10 0.0005
679 TINNITUS 24 0.0005
680 GYNAECOMASTIA 16 0.0005
681 APHTHOUS ULCER 4 0.0005
682 PULMONARY OEDEMA 23 0.0005
683 CEREBROVASCULAR ACCIDENT 87 0.0005
684 PHARYNGEAL SWELLING 5 0.0005
685 BALANCE DISORDER 44 0.0005
686 BODY TEMPERATURE DECREASED 5 0.0005
687 HYPERSENSITIVITY 94 0.0005
688 TYPE 2 DIABETES MELLITUS 17 0.0005
689 INABILITY TO AFFORD MEDICATION 5 0.0005
690 RASH ERYTHEMATOUS 24 0.0005
691 RASH GENERALISED 13 0.0005
692 MUSCULOSKELETAL PAIN 26 0.0005
693 HYPOGLYCAEMIA 24 0.0005
694 BURSITIS 6 0.0005
695 RESTLESSNESS 18 0.0005
696 INTENTIONAL DOSE OMISSION 14 0.0005
697 CONFUSIONAL STATE 79 0.0005
698 GAIT DISTURBANCE 92 0.0005
699 SUDDEN DEATH 5 0.0005
700 HYPOTHYROIDISM 15 0.0005
701 HYPOPHAGIA 12 0.0005
702 NECK PAIN 26 0.0005
703 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 24 0.0005
704 DIABETIC KETOACIDOSIS 11 0.0005
705 TREATMENT NONCOMPLIANCE 25 0.0005
706 OSTEONECROSIS 15 0.0005
707 PERIPHERAL SWELLING 70 0.0005
708 DISORIENTATION 18 0.0005
709 URTICARIA 76 0.0005
710 DECREASED APPETITE 105 0.0005
711 LYMPHADENOPATHY 16 0.0005
712 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
713 THERAPY PARTIAL RESPONDER 7 0.0004
714 COLITIS 17 0.0004
715 DYSPHAGIA 42 0.0004
716 PAIN IN EXTREMITY 130 0.0004
717 IMPAIRED GASTRIC EMPTYING 6 0.0004
718 RESPIRATORY DISTRESS 12 0.0004
719 HYPOAESTHESIA 65 0.0004
720 INTERSTITIAL LUNG DISEASE 21 0.0004
721 MUSCLE TIGHTNESS 7 0.0004
722 PRODUCT USE IN UNAPPROVED INDICATION 107 0.0004
723 EYELID OEDEMA 5 0.0004
724 MEMORY IMPAIRMENT 59 0.0004
725 DEMENTIA 12 0.0004
726 BLOOD CHOLESTEROL INCREASED 20 0.0004
727 SPLENOMEGALY 5 0.0004
728 FALL 142 0.0004
729 FLATULENCE 24 0.0004
730 INTENTIONAL PRODUCT MISUSE 37 0.0004
731 PRODUCT PRESCRIBING ERROR 10 0.0004
732 CHOLECYSTITIS 5 0.0004
733 COUGH 117 0.0004
734 ADRENAL INSUFFICIENCY 5 0.0004
735 INSOMNIA 109 0.0004
736 PRURITUS 156 0.0004
737 JOINT SWELLING 49 0.0004
738 URINARY INCONTINENCE 12 0.0004
739 DRUG INTOLERANCE 39 0.0004
740 PLATELET COUNT DECREASED 43 0.0004
741 DELIRIUM 14 0.0004
742 PRODUCTIVE COUGH 19 0.0004
743 MENTAL STATUS CHANGES 11 0.0004
744 TASTE DISORDER 8 0.0004
745 DISCOMFORT 24 0.0004
746 VIRAL INFECTION 13 0.0004
747 UPPER RESPIRATORY TRACT INFECTION 18 0.0004
748 THYROID DISORDER 6 0.0004
749 PERITONITIS 8 0.0004
750 DEVICE MALFUNCTION 27 0.0004
751 ABDOMINAL PAIN UPPER 79 0.0004
752 JOINT STIFFNESS 10 0.0004
753 MOUTH ULCERATION 8 0.0004
754 BLOOD PRESSURE INCREASED 58 0.0004
755 DEPRESSION 86 0.0004
756 DEHYDRATION 50 0.0004
757 SENSORY DISTURBANCE 6 0.0004
758 PSYCHOTIC DISORDER 11 0.0004
759 HALLUCINATION 28 0.0004
760 SUICIDAL IDEATION 34 0.0004
761 NEPHROLITHIASIS 17 0.0004
762 PARAESTHESIA 58 0.0004
763 GASTROINTESTINAL DISORDER 33 0.0004
764 SYSTEMIC LUPUS ERYTHEMATOSUS 13 0.0004
765 HEPATIC FAILURE 11 0.0004
766 RENAL DISORDER 17 0.0004
767 ABDOMINAL PAIN 84 0.0004
768 DIVERTICULITIS 10 0.0004
769 SNEEZING 8 0.0004
770 PANIC ATTACK 13 0.0004
771 DIARRHOEA 230 0.0004
772 BLINDNESS UNILATERAL 5 0.0004
773 MUSCULOSKELETAL STIFFNESS 31 0.0004
774 HEART RATE INCREASED 35 0.0004
775 SWELLING FACE 23 0.0004
776 WEIGHT DECREASED 98 0.0004
777 OEDEMA 19 0.0003
778 TACHYCARDIA 31 0.0003
779 HYPERSOMNIA 10 0.0003
780 CARDIAC FAILURE CONGESTIVE 28 0.0003
781 HYPERTHYROIDISM 5 0.0003
782 VISION BLURRED 47 0.0003
783 HEAD DISCOMFORT 6 0.0003
784 LIVER DISORDER 15 0.0003
785 AMNESIA 22 0.0003
786 PNEUMONIA 109 0.0003
787 GALLBLADDER DISORDER 6 0.0003
788 COLON CANCER 5 0.0003
789 THERAPEUTIC PRODUCT EFFECT DECREASED 15 0.0003
790 FATIGUE 259 0.0003
791 VISUAL ACUITY REDUCED 11 0.0003
792 LETHARGY 19 0.0003
793 HYPERGLYCAEMIA 12 0.0003
794 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
795 IRRITABLE BOWEL SYNDROME 7 0.0003
796 CARDIOMEGALY 4 0.0003
797 DEVICE RELATED INFECTION 5 0.0003
798 BONE PAIN 19 0.0003
799 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
800 LUNG INFECTION 5 0.0003
801 MUSCLE SPASMS 59 0.0003
802 MIDDLE INSOMNIA 6 0.0003
803 ILLNESS 33 0.0003
804 OEDEMA PERIPHERAL 39 0.0003
805 INTENTIONAL PRODUCT USE ISSUE 28 0.0003
806 CYANOSIS 5 0.0003
807 WEIGHT INCREASED 71 0.0003
808 ARTHRALGIA 131 0.0003
809 DIABETES MELLITUS 24 0.0003
810 ULCER 5 0.0003
811 RASH PRURITIC 17 0.0003
812 BRONCHITIS 23 0.0003
813 INFLAMMATION 16 0.0003
814 DEATH 267 0.0003
815 TREMOR 51 0.0003
816 DRUG INEFFECTIVE 404 0.0003
817 OFF LABEL USE 268 0.0003
818 DISABILITY 6 0.0003
819 PHOTOSENSITIVITY REACTION 5 0.0003
820 BLISTER 17 0.0003
821 ANXIETY 86 0.0003
822 NAUSEA 237 0.0003
823 DYSURIA 11 0.0003
824 PERICARDITIS 5 0.0003
825 INFECTION 43 0.0003
826 CANDIDA INFECTION 5 0.0003
827 THROAT TIGHTNESS 8 0.0003
828 PULMONARY EMBOLISM 28 0.0003
829 BLOOD GLUCOSE INCREASED 55 0.0003
830 INTESTINAL OBSTRUCTION 11 0.0003
831 MENTAL IMPAIRMENT 7 0.0003
832 ABDOMINAL DISTENSION 30 0.0003
833 VOMITING 135 0.0003
834 ROAD TRAFFIC ACCIDENT 12 0.0003
835 PANCYTOPENIA 16 0.0003
836 LUNG DISORDER 14 0.0003
837 LYMPHOCYTE COUNT DECREASED 5 0.0003
838 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
839 CELLULITIS 14 0.0003
840 TREATMENT FAILURE 23 0.0003
841 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
842 OSTEOMYELITIS 5 0.0003
843 CONSTIPATION 60 0.0003
844 ASTHMA 31 0.0003
845 ERYTHEMA 56 0.0003
846 PYREXIA 94 0.0003
847 BLINDNESS 11 0.0003
848 GAIT INABILITY 9 0.0003
849 BACTERIAL INFECTION 5 0.0003
850 SWELLING 25 0.0003
851 PHOTOPHOBIA 5 0.0003
852 LACRIMATION INCREASED 8 0.0003
853 HEADACHE 166 0.0003
854 HYPOCALCAEMIA 5 0.0003
855 FOOT FRACTURE 5 0.0003
856 SEROTONIN SYNDROME 5 0.0003
857 NIGHTMARE 9 0.0003
858 FREQUENT BOWEL MOVEMENTS 7 0.0003
859 ERUCTATION 5 0.0003
860 VISUAL IMPAIRMENT 32 0.0003
861 MALAISE 113 0.0003
862 HYPOACUSIS 11 0.0003
863 RHEUMATOID ARTHRITIS 29 0.0003
864 NASAL CONGESTION 15 0.0003
865 BRAIN FOG 4 0.0003
866 KIDNEY INFECTION 5 0.0003
867 MENTAL DISORDER 11 0.0003
868 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
869 CATARACT 15 0.0003
870 PRESCRIBED UNDERDOSE 5 0.0003
871 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
872 ECZEMA 13 0.0002
873 NIGHT SWEATS 8 0.0002
874 FIBROMYALGIA 6 0.0002
875 PAIN 150 0.0002
876 CHOLELITHIASIS 8 0.0002
877 IMPAIRED HEALING 8 0.0002
878 RIB FRACTURE 5 0.0002
879 INFLUENZA 27 0.0002
880 PNEUMONIA ASPIRATION 6 0.0002
881 DYSARTHRIA 9 0.0002
882 ASCITES 7 0.0002
883 RENAL INJURY 7 0.0002
884 COGNITIVE DISORDER 11 0.0002
885 PRODUCT USE ISSUE 44 0.0002
886 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 42 0.0002
887 BLOOD POTASSIUM DECREASED 7 0.0002
888 RASH 100 0.0002
889 ABDOMINAL DISCOMFORT 38 0.0002
890 SEIZURE 26 0.0002
891 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
892 COVID-19 39 0.0002
893 DISEASE PROGRESSION 26 0.0002
894 STOMATITIS 13 0.0002
895 THERAPY CESSATION 11 0.0002
896 EYE DISORDER 7 0.0002
897 RENAL FAILURE ACUTE 9 0.0002
898 PAIN IN JAW 6 0.0002
899 URINARY TRACT INFECTION 36 0.0002
900 NERVOUSNESS 11 0.0002
901 DRUG PRESCRIBING ERROR 4 0.0002
902 TOXICITY TO VARIOUS AGENTS 35 0.0002
903 CHILLS 24 0.0002
904 ENCEPHALOPATHY 5 0.0002
905 BACK PAIN 47 0.0002
906 DEEP VEIN THROMBOSIS 13 0.0002
907 PSORIATIC ARTHROPATHY 8 0.0002
908 FEELING HOT 12 0.0002
909 OROPHARYNGEAL PAIN 18 0.0002
910 ARTHRITIS 15 0.0002
911 AGITATION 14 0.0002
912 MOOD SWINGS 6 0.0002
913 HIP FRACTURE 6 0.0002
914 PAIN OF SKIN 5 0.0002
915 MOOD ALTERED 5 0.0002
916 MOBILITY DECREASED 13 0.0002
917 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
918 COMPLETED SUICIDE 15 0.0002
919 SKIN DISORDER 6 0.0002
920 SOMNOLENCE 36 0.0002
921 ANGER 6 0.0002
922 SKIN DISCOLOURATION 8 0.0002
923 LABORATORY TEST ABNORMAL 5 0.0002
924 SKIN EXFOLIATION 14 0.0002
925 CRYING 6 0.0002
926 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 9 0.0002
927 FEELING ABNORMAL 39 0.0002
928 EMOTIONAL DISORDER 5 0.0002
929 EYE SWELLING 6 0.0002
930 NEUROPATHY PERIPHERAL 15 0.0002
931 CYSTITIS 5 0.0002
932 THROAT IRRITATION 7 0.0002
933 INTENTIONAL OVERDOSE 10 0.0002
934 NEUTROPENIA 21 0.0002
935 SPEECH DISORDER 8 0.0002
936 DYSGEUSIA 11 0.0001
937 GASTRIC DISORDER 5 0.0001
938 ABNORMAL DREAMS 4 0.0001
939 RHINORRHOEA 9 0.0001
940 FLUID RETENTION 7 0.0001
941 SINUSITIS 14 0.0001
942 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
943 INJECTION SITE MASS 5 0.0001
944 PANCREATITIS 7 0.0001
945 DRUG ABUSE 11 0.0001
946 EXPOSURE DURING PREGNANCY 8 0.0001
947 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 26 0.0001
948 THERAPY INTERRUPTED 9 0.0001
949 EYE PAIN 7 0.0001
950 INCORRECT DOSE ADMINISTERED 28 0.0001
951 ADVERSE DRUG REACTION 11 0.0001
952 LUNG NEOPLASM MALIGNANT 5 0.0001
953 OSTEOPOROSIS 5 0.0001
954 INFUSION RELATED REACTION 8 0.0001
955 FEBRILE NEUTROPENIA 8 0.0001
956 ADVERSE EVENT 11 0.0001
957 HOSPITALISATION 18 0.0001
958 OVERDOSE 25 0.0001
959 SUICIDE ATTEMPT 7 0.0001
960 ILL-DEFINED DISORDER 7 0.0001
961 VAGINAL HAEMORRHAGE 5 0.0001
962 ACCIDENTAL OVERDOSE 4 0.0001
963 PRODUCT DOSE OMISSION ISSUE 32 0.0001
964 EMOTIONAL DISTRESS 13 0.0001
965 PSORIASIS 14 0.0001
966 HERPES ZOSTER 6 0.0001
967 PRODUCT SUBSTITUTION ISSUE 6 0.0001
968 BLOOD GLUCOSE DECREASED 5 0.0001
969 BURNING SENSATION 7 0.0001
970 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
971 HOT FLUSH 7 0.0001
972 NEOPLASM MALIGNANT 6 0.0001
973 INJECTION SITE BRUISING 7 0.0001
974 EYE IRRITATION 5 0.0001
975 DRY MOUTH 7 0.0001
976 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
977 INFLUENZA LIKE ILLNESS 7 0.0001
978 DRY EYE 4 0.0001
979 AGGRESSION 4 0.0001
980 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
981 DRY SKIN 10 0.0001
982 MIGRAINE 7 0.0001
983 NO ADVERSE EVENT 12 0.0001
984 NASOPHARYNGITIS 12 0.0001
985 PROSTATE CANCER 5 0.0001
986 ALOPECIA 12 0.0001
987 FLUSHING 6 0.0001
988 BREAST CANCER 5 0.0001
989 DRUG DOSE OMISSION 8 0.0000
990 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
991 PRODUCT QUALITY ISSUE 6 0.0000
992 INJECTION SITE PAIN 11 0.0000